메뉴 건너뛰기
Annals of Hematology
Volumn 93, Issue 3, 2014, Pages 525-527
Nephrolithiasis in patients exposed to deferasirox and desferioxamine: Probably an age-linked event with different effects on some renal parameters
Author keywords

[No Author keywords available]
Indexed keywords

ADULT; AGING; BENZOATES; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHELATION THERAPY; DEFEROXAMINE; DISEASE SUSCEPTIBILITY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERURICEMIA; INCIDENCE; IRON CHELATING AGENTS; IRON OVERLOAD; ITALY; KIDNEY; MALE; NEPHROLITHIASIS; RETROSPECTIVE STUDIES; TRIAZOLES;
EID: 84894351741     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-013-1833-y     Document Type: Letter
Times cited : (8)
References (5)
  • 1
    • 84872345100 scopus 로고    scopus 로고
    • Nephrolithiasis in beta thalassemia major patients treated with deferasirox: An advent or an adverse event? A single Greek center experience
    • 10.1007/s00277-012-1558-3 22933235
    • Efthimia V, Neokleous N, Agapidou A, Economou M, Vetsiou E, Teli A, Perifanis V (2013) Nephrolithiasis in beta thalassemia major patients treated with deferasirox: an advent or an adverse event? A single Greek center experience. Ann Hematol 92:263-265
    • (2013) Ann Hematol , vol.92 , pp. 263-265
    • Efthimia, V.1    Neokleous, N.2    Agapidou, A.3    Economou, M.4    Vetsiou, E.5    Teli, A.6    Perifanis, V.7
  • 2
    • 51649125405 scopus 로고    scopus 로고
    • Renal function in children with beta-thalassemia major and thalassemia intermedia
    • 10.1007/s00467-008-0897-8 18581145
    • Smolkin V, Halevy R, Levin C, Mines M, Sakran W, Ilia K, Koren A (2008) Renal function in children with beta-thalassemia major and thalassemia intermedia. Pediatr Nephrol 23:1847-1851
    • (2008) Pediatr Nephrol , vol.23 , pp. 1847-1851
    • Smolkin, V.1    Halevy, R.2    Levin, C.3    Mines, M.4    Sakran, W.5    Ilia, K.6    Koren, A.7
  • 3
    • 84865146001 scopus 로고    scopus 로고
    • Renal aspects of thalassaemia a changing paradigm
    • 1:CAS:528:DC%2BC38XhsVensLjL 10.1111/j.1600-0609.2012.01819.x 22687050
    • Bhandari S, Galanello R (2012) Renal aspects of thalassaemia a changing paradigm. Eur J Haematol 89:187-197
    • (2012) Eur J Haematol , vol.89 , pp. 187-197
    • Bhandari, S.1    Galanello, R.2
  • 4
    • 84865983118 scopus 로고    scopus 로고
    • Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: A retrospective study
    • 1:CAS:528:DC%2BC38XovVGlurw%3D 10.1016/j.bcmd.2012.05.012 22705193
    • Ricchi P, Ammirabile M, Costantini S, Di Matola T, Spasiano A, Genna ML, Cinque P, Prossomariti L (2012) Splenectomy is a risk factor for developing hyperuricemia and nephrolithiasis in patients with thalassemia intermedia: a retrospective study. Blood Cells Mol Dis 49:133-135
    • (2012) Blood Cells Mol Dis , vol.49 , pp. 133-135
    • Ricchi, P.1    Ammirabile, M.2    Costantini, S.3    Di Matola, T.4    Spasiano, A.5    Genna, M.L.6    Cinque, P.7    Prossomariti, L.8
  • 5
    • 33646414765 scopus 로고    scopus 로고
    • Phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassaemia
    • 1:CAS:528:DC%2BD28Xkt1Git7k%3D 10.1182/blood-2005-08-3430 16352812
    • Cappellini MD, Cohen A, Piga A et al (2006) Phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassaemia. Blood 107:3455-3462
    • (2006) Blood , vol.107 , pp. 3455-3462
    • Cappellini, M.D.1    Cohen, A.2    Piga, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.